Overactive Bladder
Conditions
Keywords
overactive bladder, children, oxybutynin, propiverine, tolterodine
Brief summary
This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.
Detailed description
A total of approximately 150 patients with overactive bladder will be evaluated retrospectively. Clinical and demographic data and voiding diaries of these patients will be evaluated. For this purpose, patients will be divided into mainly three groups according to the anticholinergic agent used.
Interventions
DRUGOxybutynin Cl
Oxybutynin in a dose of 0.5 mg/kg will be used in the treatment of overactive bladder
DRUGpropiverine
Propiverine in a dose of 0.8 mg/kg will be used in the treatment of overactive bladder
DRUGTolterodine
Tolterodine in a dose of 0.1 mg/kg will be used in the treatment of overactive bladder
Sponsors
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with overactive bladder * Patients treated with an anticholinergic
Exclusion criteria
* Presence of anatomical or neurological problems * Patients with missing data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients treated with anticholinergic | 6 months |
| Number of patients with drug related adverse effects | 1 month |
Countries
Turkey (Türkiye)
Outcome results
None listed